Science News
from research organizations

Researchers identify genetic markers linking risk for both type 2 diabetes, Alzheimer’s disease

Date:
July 16, 2015
Source:
Mount Sinai Medical Center
Summary:
A study sheds light on the influences of genetics on why some type 2 diabetics are at high risk for developing Alzheimer’s disease. While previous studies strongly suggested a causative role of diabetes in the onset and progression of Alzheimer’s disease dementia, the specific mechanistic interactions connecting diabetes and Alzheimer’s disease had not been previously described.
Share:
FULL STORY

Certain patients with type 2 diabetes (T2D) may have specific genetic risk factors that put them at higher risk for developing Alzheimer's disease (AD), according to a study conducted at the Icahn School of Medicine at Mount Sinai and published recently in Molecular Aspects of Medicine.

Under the leadership of Giulio Maria Pasinetti, MD, PhD, Saunders Family Chair and Professor of Neurology at the Icahn School of Medicine at Mount Sinai and Director of Biomedical Training in the Geriatric Research Education and Clinical Centers at J.J. Peters Bronx VA Medical Center, the study team used recent genome wide association study (GWAS) findings to investigate whether T2D and AD share common genetic etiological factors and the potential impact of these genetic factors on the cellular and molecular mechanisms that may contribute to the development of both these diseases.

GWAS look at differences at many points in the genetic code to see if, across a population, one or more variations in the code are found more often in those with a given trait (for example, high risk for a disease). Even the smallest genetic variations, called single nucleotide polymorphisms (SNPs), can have a major impact on a trait by swapping just one of the 3.2 billion "letters" that make up the human DNA code.

One of the major long-term complications of T2D is an increased risk for developing AD. While previous studies strongly suggested a causative role of diabetes in the onset and progression of AD dementia, the specific mechanistic interactions connecting diabetes and AD had not been previously described.

"We identified multiple genetic differences in terms of SNPs that are associated with higher susceptibility to develop type 2 diabetes as well as Alzheimer's disease," says Dr. Pasinetti. "Many of these SNPs are traced to genes whose anomalies are known to contribute to T2D and AD, suggesting that certain diabetic patients with these genetic differences are at high risk for developing Alzheimer's. Our data highlights the need for further exploration of genetic susceptibility to Alzheimer's disease in patients with T2D."

An estimated 312 million people suffer from T2D worldwide, exerting enormous burdens on individuals and on health care systems. Similarly, AD affects nearly 45 million people worldwide and is costly to both individuals and healthcare systems. There is currently no cure for either condition.

Mounting evidence suggests that AD dementia can be traced back to pathological conditions, such as T2D, that are initiated several decades before clinical AD onset. Since T2D is one of the potentially modifiable risk factors for AD, it is critically important for scientists to uncover the genetics of this complex connection so that new therapeutic interventions may be developed and targeted to at-risk individuals with T2D prior to the onset of AD dementia.

This study will support ongoing research applications to further explore genetic susceptibility in patients with T2D for developing AD and help improve the design of future novel treatments for a subpopulation of T2D subjects with genetic predisposition to AD, which could benefit T2D and reduce the risk for subsequent development of AD. Outcomes from these studies identifying cellular abnormalities common to both T2D and AD can lead to the development of T2D therapies that may also help prevent subsequent development of AD in genetically predisposed individuals.


Story Source:

Materials provided by Mount Sinai Medical Center. Note: Content may be edited for style and length.


Journal Reference:

  1. Ke Hao, Antonio Fabio Di Narzo, Lap Ho, Wei Luo, Shuyu Li, Rong Chen, Tongbin Li, Lauren Dubner, Giulio Maria Pasinetti. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes. Molecular Aspects of Medicine, 2015; DOI: 10.1016/j.mam.2015.06.006

Cite This Page:

Mount Sinai Medical Center. "Researchers identify genetic markers linking risk for both type 2 diabetes, Alzheimer’s disease." ScienceDaily. ScienceDaily, 16 July 2015. <www.sciencedaily.com/releases/2015/07/150716161054.htm>.
Mount Sinai Medical Center. (2015, July 16). Researchers identify genetic markers linking risk for both type 2 diabetes, Alzheimer’s disease. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2015/07/150716161054.htm
Mount Sinai Medical Center. "Researchers identify genetic markers linking risk for both type 2 diabetes, Alzheimer’s disease." ScienceDaily. www.sciencedaily.com/releases/2015/07/150716161054.htm (accessed May 23, 2017).

RELATED STORIES